DBIA
BMY icon

Dumont & Blake Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-800
Closed -$45K – 176
2020
Q1 		$45K Buy
+800
New +$48.9K 0.02% 159
2017
Q1 		– Sell
-5,600
Closed -$327K – 185
2016
Q4 		$327K Hold
5,600
– – 0.15% 139
2016
Q3 		$302K Buy
+5,600
New +$360K 0.15% 138

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dumont & Blake Investment Advisors's BMY Position: Q2 2026 in Review

Dumont & Blake Investment Advisors reduced its Bristol-Myers Squibb (BMY) stake by 2.2% in Q2 2026, selling an estimated $9.65K and leaving 7,378 shares worth $425K. The position accounts for 0.1% of the portfolio, ranked #149.

Dumont & Blake Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.9M in Q2 2022. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Dumont & Blake Investment Advisors held 7,378 shares of Bristol-Myers Squibb worth $425K as of Q2 2026.
  • Dumont & Blake Investment Advisors sold 168 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.65K.
  • Bristol-Myers Squibb made up 0.1% of Dumont & Blake Investment Advisors's portfolio in Q2 2026, its #149 holding.
  • Dumont & Blake Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Dumont & Blake Investment Advisors's Bristol-Myers Squibb position peaked at $1.9M in Q2 2022.
  • 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.